Company profile: IQuum
1.1 - Company Overview
Company description
- Provider of molecular diagnostics and biological sample technology, developing an early-stage platform to improve extraction of information from biological samples and deliver recent advances in genomics and biotechnology to healthcare and daily life; founded in 1998 in the Boston metropolitan area.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IQuum
Great Basin Scientific
HQ: United States
Website
- Description: Provider of molecular, rapid diagnostic testing solutions, featuring the Great Basin Diagnostic System, a fully automated sample-to-result platform with integrated reagents and internal controls. Offers assays including Staph ID/R Blood Culture Panel, Stool Bacterial Pathogens, C. diff, Group B Strep, and Shiga Toxin Direct tests.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Great Basin Scientific company profile →
TriPharm
HQ: United States
Website
- Description: Provider of pharmaceuticals as a privately held pharmaceuticals company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriPharm company profile →
OLM Diagnostics
HQ: United Kingdom
Website
- Description: Provider of fungal and bacterial diagnostic solutions for healthcare providers, including: AspLFD, a lateral flow device detecting Aspergillus antigens in 15–40 minutes; AspID and PneumID real-time PCR kits for Aspergillus species (90 minutes) and Pneumocystis jirovecii (45 minutes); CandID for early Candida bloodstream detection; and AurisID for identifying Candida auris.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OLM Diagnostics company profile →
Spero Therapeutics
HQ: United States
Website
- Description: Provider of oral and IV antibiotic therapies for gram-negative infections: Tebipenem HBr for complicated urinary tract infections and acute pyelonephritis to reduce hospitalizations and support transition from IV to home care; SPR720, an oral investigational agent for nontuberculous mycobacterial pulmonary disease; and SPR206, an IV candidate for multidrug-resistant Gram-negative infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Spero Therapeutics company profile →
Revive Therapeutics
HQ: Canada
Website
- Description: Provider of therapeutics and diagnostics, including Bucillamine, an oral thiol-based drug being developed for COVID-19, long COVID, other infectious diseases, and rare inflammatory disorders; psilocybin-based therapeutics for mental illnesses and substance use disorders; CBD therapeutics for autoimmune hepatitis and transplant injury prevention; and a point-of-care lateral flow test for post-COVID-19 conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Revive Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IQuum
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IQuum
2.2 - Growth funds investing in similar companies to IQuum
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IQuum
4.2 - Public trading comparable groups for IQuum
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →